Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: Results from a phase-I trial

Radiotherapy and Oncology ◽

10.1016/j.radonc.2019.08.007 ◽

2020 ◽

Vol 142 ◽

pp. 79-84 ◽

Cited By ~ 5

Author(s):

Joris B.W. Elbers ◽

Abrahim Al-Mamgani ◽

Margot E.T. Tesseslaar ◽

Michiel W.M. van den Brekel ◽

Charlotte A.H. Lange ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Trial ◽

Neck Squamous Cell Carcinoma ◽

Advanced Stage

Download Full-text

A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101

Oral Oncology ◽

10.1016/j.oraloncology.2020.105171 ◽

2021 ◽

Vol 114 ◽

pp. 105171

Author(s):

Michael J. Jelinek ◽

Nathan R. Foster ◽

Alex J. Zoroufy ◽

Gary K. Schwartz ◽

Pamela N. Munster ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Trial ◽

Neck Squamous Cell Carcinoma ◽

Polymerase Inhibitor

Download Full-text

Elderly patients with locally advanced head and neck squamous cell carcinoma treated with NBTXR3 nanoparticles activated by radiotherapy: A phase I trial

Annals of Oncology ◽

10.1093/annonc/mdy287.014 ◽

2018 ◽

Vol 29 ◽

pp. viii377-viii378

Author(s):

C. Le Tourneau ◽

V. Calugaru ◽

V. Moreno ◽

X. Mirabel ◽

B. Dodger ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Elderly Patients ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Trial ◽

Locally Advanced ◽

Neck Squamous Cell Carcinoma ◽

Advanced Head

Download Full-text

A phase I trial of the addition of the CDK 4/6 inhibitor palbociclib to cetuximab in patients with incurable head and neck squamous cell carcinoma (HNSCC).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.6043 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 6043-6043 ◽

Cited By ~ 3

Author(s):

Loren S. Michel ◽

Jessica C. Ley ◽

Tanya Marya Wildes ◽

Kathryn Trinkaus ◽

Douglas Adkins

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Trial ◽

Neck Squamous Cell Carcinoma

Download Full-text

Abstract LB-252: Ketogenic diet with concurrent chemoradiation in head and neck squamous cell carcinoma: Pre-clinical and phase I trial results

10.1158/1538-7445.am2018-lb-252 ◽

2018 ◽

Author(s):

Daniel MA ◽

Carryn Anderson ◽

Samuel N. Rodmann ◽

Kayla Follmer ◽

Visarut Buranasudja ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Ketogenic Diet ◽

Squamous Cell ◽

Phase I Trial ◽

Neck Squamous Cell Carcinoma ◽

Concurrent Chemoradiation

Download Full-text

Phase I trial with the CD44v6-targeting immunoconjugate bivatuzumab mertansine in head and neck squamous cell carcinoma

Oral Oncology ◽

10.1016/j.oraloncology.2007.10.009 ◽

2008 ◽

Vol 44 (9) ◽

pp. 823-829 ◽

Cited By ~ 91

Author(s):

Herbert Riechelmann ◽

Alexander Sauter ◽

Wolfram Golze ◽

Gertraud Hanft ◽

Carsten Schroen ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Trial ◽

Neck Squamous Cell Carcinoma

Download Full-text

Phase I trial of copanlisib, a selective PI3K inhibitor, in combination with cetuximab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma

Investigational New Drugs ◽

10.1007/s10637-021-01152-z ◽

2021 ◽

Author(s):

Grégoire Marret ◽

Nicolas Isambert ◽

Keyvan Rezai ◽

Jocelyn Gal ◽

Esma Saada-Bouzid ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Trial ◽

Pi3k Inhibitor ◽

Neck Squamous Cell Carcinoma

Download Full-text

Phase I trial of oral etoposide in combination with radiotherapy in head and neck squamous cell carcinoma - GORTEC 2004–02

Radiation Oncology ◽

10.1186/1748-717x-8-40 ◽

2013 ◽

Vol 8 (1) ◽

pp. 40 ◽

Cited By ~ 4

Author(s):

Yungan Tao ◽

Etienne Bardet ◽

Dominique Rosine ◽

Frédéric Rolland ◽

Emmanuelle Bompas ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Trial ◽

Neck Squamous Cell Carcinoma ◽

Oral Etoposide

Download Full-text

Phase I trial of palbociclib, a selective cyclin dependent kinase 4/6 inhibitor, in combination with cetuximab in patients with recurrent/metastatic head and neck squamous cell carcinoma

Oral Oncology ◽

10.1016/j.oraloncology.2016.05.011 ◽

2016 ◽

Vol 58 ◽

pp. 41-48 ◽

Cited By ~ 43

Author(s):

Loren Michel ◽

Jessica Ley ◽

Tanya M. Wildes ◽

András Schaffer ◽

Anthony Robinson ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Trial ◽

Neck Squamous Cell Carcinoma ◽

Cyclin Dependent Kinase

Download Full-text

A phase I trial of pazopanib (suspension formulation) added to a fixed dose of cetuximab in patients with incurable head and neck squamous cell carcinoma (HNSCC).

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e17028 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e17028-e17028

Author(s):

Douglas Adkins ◽

Jessica C. Ley ◽

Tanya Marya Wildes ◽

Kathryn Trinkaus ◽

Marilyn Siegel ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Trial ◽

Neck Squamous Cell Carcinoma ◽

Fixed Dose ◽

Suspension Formulation

Download Full-text

A phase I trial combining oral cisplatin (CP Ethypharm) with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma

Radiotherapy and Oncology ◽

10.1016/j.radonc.2010.11.008 ◽

2011 ◽

Vol 98 (1) ◽

pp. 42-47 ◽

Cited By ~ 7

Author(s):

Yungan Tao ◽

Keyvan Rezaï ◽

Etienne Brain ◽

Atoussa Etessami ◽

Antoine Lusinchi ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Phase I Trial ◽

Locally Advanced ◽

Neck Squamous Cell Carcinoma ◽

Advanced Head

Download Full-text